GC Biopharma

GC Biopharma EPS

The Earnings per Share (EPS) of GC Biopharma (006280.KS) as of Oct 16, 2026 is -409.51 KRW. In the previous year, Earnings per Share (EPS) was -2,302.62 KRW — a change of -82.22% (higher).

EPS

-409.51KRW

YoY

-82.22%

Last updated:

Earnings per Share (EPS) of GC Biopharma is 2025 -409.51 KRW. Earnings per Share (EPS) of GC Biopharma was 2024 -2,302.62 KRW. It decreases by -82.22% higher compared to the previous year.

The GC Biopharma EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2021
10,795.55 KRW
Jan 1, 2022
5,734.86 KRW
Jan 1, 2023
-2,333.42 KRW
Jan 1, 2024
-2,302.62 KRW
Jan 1, 2025
-409.51 KRW
Jan 1, 2026 (e)
15,736.91 KRW
Jan 1, 2027 (e)
4,159.13 KRW
Jan 1, 2028 (e)
7,167.71 KRW
The GC Biopharma EPS history
YEAREPSYoY
est7,167.71KRW+72.34%
est4,159.13KRW-73.57%
est15,736.91KRW-3,942.85%
-409.51KRW-82.22%
-2,302.62KRW-1.32%
-2,333.42KRW-140.69%
5,734.86KRW-46.88%
10,795.55KRW+52.02%
7,101.33KRW-2,328.12%
-318.71KRW-110.57%
3,016.64KRW+144.43%
1,234.13KRW-77.41%
5,462.08KRW-34.36%
8,320.84KRW+13.13%
7,355.08KRW+19.81%
6,139.06KRW+30.62%
4,700.08KRW-3.11%
4,851.14KRW-47.11%
9,172.59KRW+13.91%
8,052.40KRW+64.76%
4,887.30KRW+10.18%
4,435.70KRW+45.50%
3,048.51KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

GC Biopharma Stock analysis

What does GC Biopharma do? GC Biopharma Corp, headquartered in Yongin, South Korea, operates in the Health Care sector, specifically within Biotechnology. The company manufactures and sells pharmaceutical products such as blood products, vaccines, OTC drugs, diagnostic reagents, cell therapies, and genome analysis services. Listed on 1 August 1989, it serves the South Korean market with a focus on innovative biopharmaceutical solutions. GC Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GC Biopharma stock

Earnings per Share (EPS) of GC Biopharma is -409.51 KRW in 2025.

Earnings per Share (EPS) of GC Biopharma changed from -2,302.62 KRW to -409.51 KRW, representing a -82.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) GC Biopharma since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — GC Biopharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — GC Biopharma